{"disease":{"id":"genital-herpes-simplex-type-2","name":"genital herpes simplex type 2"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02910284","title":"Long-term Follow-up of GEN-003-002 Subjects for Efficacy and Immunogenicity","phase":"","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Genocea Biosciences, Inc.","has_results":false},{"nct_id":"NCT06385327","title":"A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital Herpes","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":115,"lead_sponsor_name":"Assembly Biosciences","has_results":false},{"nct_id":"NCT06698575","title":"A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"Assembly Biosciences","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}